In this framework, the significant association between the occurrence of neoplasms and the use of biotechnological agents, including IL-1 inhibitors (Figure 1), observed towards Still’s disease and Behçet’s disease may lie. The gene discussed is IL1B; the disease is systemic-onset juvenile idiopathic arthritis.